Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-aminopropanal (3-AP) is a highly reactive aminoaldehyde generated as a byproduct of polyamine metabolism, specifically through the oxidation of spermine and spermidine by the enzyme polyamine oxidase (PAO) [PubChem CID 119611]. It is primarily recognized for its potent neurotoxic properties, playing a significant role in the pathogenesis of brain injury following cerebral ischemia and in neurodegenerative diseases such as Alzheimer's [PubMed: 9723013]. The molecule induces cellular damage by promoting oxidative stress, causing protein carbonylation, and triggering lysosomal membrane rupture, which leads to both apoptotic and necrotic cell death [PubMed: 16461336]. While 3-aminopropanal is not a therapeutic target in the form of a receptor or enzyme, it is a critical pathogenic mediator whose production is targeted for inhibition. Experimental strategies to mitigate its effects include the use of polyamine oxidase inhibitors like MDL-72527 or aldehyde scavengers like aminoguanidine to prevent the accumulation of this toxic metabolite [PubMed: 12127011].
Prevention of 3-aminopropanal formation via polyamine oxidase inhibition or direct chemical neutralization by aldehyde scavengers.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-aminopropanal (3-AP) (3-AP).